We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+8.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$36.4B
AUM Growth
+$3.53B
(+11%)
Cap. Flow
+$1.12B
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
20.83%
Holding
3,908
New
299
Increased
2,042
Reduced
1,302
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$67.7M |
| 2 |
Invesco NASDAQ 100 ETF
QQQM
|
+$38.1M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$24.7M |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$24.2M |
| 5 |
Capital Group Growth ETF
CGGR
|
+$21.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$27.2M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$22.4M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$16.6M |
| 4 |
First Trust Value Line Dividend Fund
FVD
|
+$13.3M |
| 5 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.56% |
| 2 | Financials | 4.99% |
| 3 | Consumer Discretionary | 3.69% |
| 4 | Communication Services | 3.04% |
| 5 | Industrials | 2.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Janus Henderson Small Cap Growth Alpha ETF
JSML
$381M
| $8.81M | 0.02% |
117,830
+4,898
| +4% | +$348K |
|
627
Nike
NKE
$60.1B
| $8.8M | 0.02% |
126,251
+4,587
| +4% | +$342K |
|
|
628
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $8.79M | 0.02% |
114,534
-175,588
| -61% | -$13.1M |
|
629
Elevance Health
ELV
$86.6B
| $8.76M | 0.02% |
27,118
-1,850
| -6% | -$575K |
|
630
IonQ
IONQ
$18.3B
| $8.76M | 0.02% |
142,448
+18,518
| +15% | +$871K |
|
631
Shell
SHEL
$249B
| $8.74M | 0.02% |
122,132
-7,821
| -6% | -$563K |
|
632
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$637M
| $8.66M | 0.02% |
388,916
+11,934
| +3% | +$261K |
|
633
Mondelez International
MDLZ
$79.4B
| $8.62M | 0.02% |
137,988
-95
| -0.1% | -$6.13K |
|
634
VICI Properties
VICI
$28.7B
| $8.6M | 0.02% |
263,647
+7,869
| +3% | +$259K |
|
635
Pacer Trendpilot US Mid Cap ETF
PTMC
$406M
| $8.59M | 0.02% |
239,872
+22,805
| +11% | +$802K |
|
636
Vanguard International Dividend Appreciation ETF
VIGI
$9.28B
| $8.59M | 0.02% |
95,842
+4,493
| +5% | +$400K |
|
637
iShares US Medical Devices ETF
IHI
$3.48B
| $8.57M | 0.02% |
142,662
-4,821
| -3% | -$295K |
|
638
Dimensional Core Fixed Income ETF
DFCF
$10.9B
| $8.54M | 0.02% |
199,655
+5,065
| +3% | +$215K |
|
639
Jackson Financial
JXN
$8.85B
| $8.47M | 0.02% |
83,703
-1,486
| -2% | -$139K |
|
640
Celestica
CLS
$42.8B
| $8.46M | 0.02% |
34,330
+8,410
| +32% | +$1.7M |
|
641
Innovator Laddered Allocation Power Buffer ETF
BUFF
$942M
| $8.42M | 0.02% |
172,260
+2,926
| +2% | +$140K |
|
642
iShares Intermediate Government/Credit Bond ETF
GVI
$3.79B
| $8.41M | 0.02% |
78,329
-4,077
| -5% | -$436K |
|
643
Strategas Macro Thematic Opportunities ETF
SAMT
$881M
| $8.4M | 0.02% |
225,317
+5,674
| +3% | +$201K |
|
644
Ecolab
ECL
$78.1B
| $8.38M | 0.02% |
30,580
-1,829
| -6% | -$497K |
|
645
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
| $8.34M | 0.02% |
124,750
-3,189
| -2% | -$206K |
|
646
T. Rowe Price US Equity Research ETF
TSPA
$4.44B
| $8.34M | 0.02% |
198,995
+65,833
| +49% | +$2.65M |
|
647
iShares Morningstar Value ETF
ILCV
$1.35B
| $8.34M | 0.02% |
92,627
+4,095
| +5% | +$354K |
|
648
iShares Biotechnology ETF
IBB
$9.86B
| $8.32M | 0.02% |
57,650
-401
| -0.7% | -$54.7K |
|
649
Agnico Eagle Mines
AEM
$93.8B
| $8.31M | 0.02% |
49,288
+181
| +0.4% | +$24.9K |
|
|
NVO
650
Novo Nordisk
NVO
$203B
| $8.3M | 0.02% |
149,628
-58,341
| -28% | -$3.41M |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Cambridge Investment Research Advisors held 3,908 positions worth $36.4B, up 11% from $32.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Cambridge Investment Research Advisors deployed $1.12B of net new capital in Q3 2025, opening 299 new positions and adding to 2,042 existing holdings. Its largest new stake was Scharf ETF: 195,274 shares worth $11M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $27.2M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2025 buy was Scharf ETF: 195,274 shares worth $11M.
- Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q3 2025, an estimated $67.7M increase.
- Cambridge Investment Research Advisors's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $27.2M.
- Cambridge Investment Research Advisors fully exited iShares Large Cap Deep Quarterly Laddered ETF in Q3 2025, selling an estimated $8.43M.
- Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $36.4B portfolio in Q3 2025.
- Cambridge Investment Research Advisors opened 299 new positions and closed 193 in Q3 2025.
- Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $36.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.